THERACLION announced the launch of SONOVEIN® HD. This new system combines the first and only extracorporeal therapeutic ultrasound solution with imaging capabilities from SuperSonic Imagine (recently acquired by Hologic), made in Aix-en-Provence, France. Less than 3 years after unveiling the first SONOVEIN®, Theraclion is launching its CE-marked third-generation platform, SONOVEIN® HD.

This new edition is the result of Theraclion research team's technical developments and the integration of best-in-class high-definition imaging technologies MACH30 10-12Mhz imaging system. A few days after the treatment of the first patients in the US, the SONOVEIN® HD release represents the ultimate technological milestone in Theraclion's ambition to revolutionize varicose vein treatment. Theraclion is on track to transform this large global market.

Varicose veins affect an estimated 30% of the world's adult population and require about 5 million medical procedures annually.